Search

You searched for "intravitreal"

545 results found
Ophthalmologica journal front cover image.

Steroid implants in the treatment of post-epiretinal membrane peel macular oedema

1 February 2018 | | EYE - Vitreo-Retinal
This is a retrospective review of 39 eyes of 37 patients treated with Ozurdex® (intravitreal dexamethasone implant) for persistent post-operative cystoid macular oedema (CMO) following vitrectomy and idiopathic epiretinal membrane (ERM) peeling. The 0.7mg implant was injected in each eye...
Acta Ophthalmologica cover image.

Does Ozurdex affect perfusion status in vein occlusion?

1 October 2018 | | EYE - Cataract, EYE - Refractive | intravitreal dexamethasone implant, peripheral nonperfusion, retinal vein occlusion, wide-field fluorescein angiography
Ozurdex (intravitreal dexamethasone implant) has been approved by National Institute of Health & Care Excellence (NICE) for treatment of patients with macular oedema associated with vein occlusion. This study looks at the change in peripheral perfusion status in patients with...

Type 3 CNV and anti-VEGF

1 February 2019 | | EYE - Vitreo-Retinal
The purpose of the study was to determine the differences between aflibercept and ranibizumab in terms of their therapeutic efficacy in the treatment of Type 3 neovascularisation. The authors highlight that the dominant mechanism for Type 3 neovascularisation development is...

Ranibizumab safety in pregnancy

1 December 2018 | | EYE - Vitreo-Retinal
Vascular endothelial growth factor (VEGF) plays a pivotal role during pregnancy, and systemic anti-VEGF administration during this period should thus be avoided. VEGF is expressed in multiple embryonic and foetal tissues during development, with the highest levels found in the...

BOS 2026

17 January 2026
Birmingham Ophthalmology Society Annual Conference

Considerations in the management of retinal disorders

1 October 2017 | | EYE - Vitreo-Retinal
Vision research presentations and publications explore practice considerations in the management of AMD and diabetic retinopathy. Over the past two decades in Europe there has been a decreasing prevalence of age-related macular degeneration (AMD) and an improvement in visual acuity...

Management of retinal diseases: highlights from the AAO 2019 Retina Subspecialty Day Meeting

2 December 2019 | | EYE - Vitreo-Retinal, EYE - General
The author highlights current debate, opinion and late breaking developments in the management of retinal diseases. The American Academy of Ophthalmology’s 2019 Retina Subspecialty Day Meeting was held on 11-12 October, 2019 in San Francisco, USA. Established and emerging innovative...

My top five: Innovative approaches to dry AMD

2 February 2024 | | EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the developing world with its prevalence rising alongside age. In societies characterised by ageing populations, it is imperative we explore more effective treatment to alleviate the...

My Top Five: Innovative approaches to dry AMD

2 February 2024 | | EYE - General
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the developing world with its prevalence rising alongside age. In societies characterised by ageing populations, it is imperative we explore more effective treatment to alleviate the...

Management of a giant pigment epithelium detachment with transition from half- to full-dose aflibercept

2 March 2026 | | EYE - Imaging, EYE - Vitreo-Retinal
This case report describes the management of a giant pigment epithelial detachment (PED) in neovascular age-related macular degeneration (nAMD) using half-dose aflibercept. An 80-year-old woman presented with a huge PED (maximum height 1338µm) and multiple risk factors for retinal pigment...

Moorfields medical retina consent pathways course

28 February 2025
This brand new, unique MR Pathways consent course is specially designed for nurses, optometrists, doctors and others healthcare professional groups working in medical retina subspeciality in ophthalmology. The MR Pathway consent course enables the multi professional groups to embed the...

Moorfields: Medical retina pathways consent course

3 October 2025
This brand new, unique MR Pathways consent course is specially designed for nurses, optometrists, doctors and others healthcare professional groups working in medical retina subspeciality in ophthalmology. The MR Pathway consent course enables the multi professional groups to embed the...